Chief Science Officer, Steep Hill Labs Inc.
Dr. Reggie Gaudino oversees all scientific research and development for Steep Hill and manages the YnsightTM genetics division. Dr. Gaudino directed a team of researchers which led to the development of GenKitTM, the first cannabis DNA-based sex test. The research from Dr. Gaudino has been peer-reviewed and published, leading to important new discoveries in the cannabis industry. He is internationally recognized as a leader in the field of cannabis genetics where his former experience as a Patent Agent with Sequenom brings valuable insight to the cannabis industry. His groundbreaking work was featured in April 2016 in Wired Magazine.
Dr. Gaudino also is the Scientific Advisor for partner company, Pathogendx, where he helps identify and commercialize DNA based testing opportunities in the cannabis industry. Dr. Gaudino and Steep Hill act as the partner laboratory for Pathogendx product development and validation testing. Dr. Gaudino also is currently advising additional cannabis companies, from both a scientific and intellectual property perspective.
Dr. Gaudino received his B.S. in Molecular Biology and Ph.D. in Molecular Genetics from the State University of New York at Buffalo, and he conducted four years of post-doctoral research at the Washington University in St. Louis, studying transcriptional regulation of rRNA. Reggie was one of the first African-American molecular biologists to enter a PhD program in the United States in 1985.